|
180
|
554
|
6o0gA |
M.tb mend bound to intermediate i and inhibitor |
|
179
|
554
|
6o04A |
M.tb mend intii bound with inhibitor |
|
162
|
553
|
6o0nA |
M.tb mend with inhibitor |
|
177
|
554
|
6o0jA |
M.tb mend with thdp and inhibitor bound |
|
120
|
347
|
6uwyA |
Dyrk1a bound to a harmine derivative |
|
76
|
299
|
6jlrA |
Crystal structure of wild type mnk2 in complex with inhibitor |
|
87
|
288
|
6ovaA |
Crystal structure of tyk2 with novel pyrrolidinone inhibitor |
|
69
|
247
|
6ntuA |
Crystal structure of human parp-1 art domain bound to inhibitor uktt-15 |
|
151
|
495
|
6nqtA |
Galnac-t2 soaked with udp-sugar |
|
151
|
426
|
6p7zA |
Co-crystal structure of human smyd3 with isoxazole amides inhibitors |
|
154
|
426
|
6p6kA |
Co-crystal structure of human smyd3 with isoxazole amides inhibitors |
|
110
|
391
|
6p5pA |
Discovery of a novel, highly potent, and selective thieno[3,2-d]pyrimidinone-based cdc7 inhibitor with a quinuclidine moiety (tak-931) as an orally active investigational anti-tumor agent |
|
148
|
426
|
6p6gA |
Co-crystal structure of human smyd3 with isoxazole amides inhibitors |
|
118
|
401
|
6p5mA |
Discovery of a novel, highly potent, and selective thieno[3,2-d]pyrimidinone-based cdc7 inhibitor with a quinuclidine moiety (tak-931) as an orally active investigational anti-tumor agent |
|
151
|
426
|
6pafA |
Co-crystal structure of human smyd3 with isoxazole amides inhibitors |
|
119
|
385
|
6nxgA |
Crystal structure of glycylpeptide n-tetradecanoyltransferase from plasmodium vivax in complex with inhibitor 303a |
|
80
|
287
|
6u5lA |
Structure of human ulk4 in complex with an inhibitor |
|
94
|
322
|
6p1dA |
Crystal structure of egfr with mutant-selective dihydrodibenzodiazepinone allosteric inhibitor |
|
82
|
307
|
6p1lA |
Crystal structure of egfr in complex with eai045 |
|
90
|
321
|
6p8qA |
Egfr in complex with a dihydrodibenzodiazepinone allosteric inhibitor. |
|
292
|
1015
|
6ocoA |
Human pi3kdelta in complex with compound 6 |
|
282
|
1012
|
6ocuA |
Human pi3kdelta in complex with compound 29 |
|
76
|
170
|
6ocoB |
Human pi3kdelta in complex with compound 6 |
|
46
|
152
|
6nujA |
Hiv-1 integrase catalytic core domain complexed with allosteric inhibitor bi-224436 |
|
76
|
168
|
6ocuB |
Human pi3kdelta in complex with compound 29 |
|
94
|
270
|
6pveA |
Structure of nicotinamide n-methyltransferase (nnmt) in complex with inhibitor ll319 |
|
95
|
270
|
6pvsA |
Structure of nicotinamide n-methyltransferase (nnmt) in complex with inhibitor ll320 |
|
67
|
274
|
6oytA |
Ask1 kinase domain in complex with gs-4997 |
|
109
|
306
|
6u6aA |
Crystal structure of yck2 from candida albicans in complex with kinase inhibitor gw461484a |
|
98
|
265
|
6u25A |
Crystal structure of rar-related orphan receptor c (nhis- rorgt(244-487)-l6-src1(678-692)) in complex with a tricyclic inverse agonist |
|
126
|
404
|
6urcA |
Crystal structure of ire1a in complex with compound 18 |
|
131
|
343
|
6oagF |
Crystal structure of human fpps in complex with an allosteric inhibitor yf-02-82 |
|
119
|
340
|
6n7zF |
Crystal structure of human fpps in complex with an allosteric inhibitor yf-02037 |
|
129
|
341
|
6n7yF |
Crystal structure of human fpps in complex with an allosteric inhibitor mit-01-102 |
|
130
|
344
|
6oahF |
Crystal structure of human fpps in complex with an allosteric inhibitor yf-02-78 |
|
135
|
343
|
6n82F |
Crystal structure of human fpps in complex with an allosteric inhibitor yf-02037 |
|
88
|
283
|
6pf6A |
Crystal structure of ts-dhfr from cryptosporidium hominis in complex with nadph, fdump and 2-(4-((2-amino-4-oxo-4,7-dihydro-3h-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)terephthalic acid |
|
161
|
519
|
6pfcA |
Crystal structure of ts-dhfr from cryptosporidium hominis in complex with nadph, fdump and 2-(2-(4-((2-amino-4-oxo-4,7-dihydro-3h-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)-4-methoxyphenyl)acetic acid |
|
100
|
297
|
6momA |
Crystal structure of human interleukin-1 receptor associated kinase 4 (irak 4, cid 100300) in complex with compound ncc00371481 (bsi 107591) |
|
70
|
209
|
6qxuA |
Human tnks1 in complex with 6,8-difluoro-2-[4-(1-hydroxy-1-methyl-ethyl)-phenyl]-3h-quinazolin-4-one |
|
83
|
285
|
6pf5A |
Crystal structure of human thymidylate synthase delta (7-29) in complex with dump and 2-(2-(4-((2-amino-4-oxo-4,7-dihydro-3h-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)-4-methoxyphenyl)acetic acid |
|
90
|
284
|
6pf4A |
Crystal structure of human thymidylate synthase delta (7-29) in complex with dump and 2-(2-(4-((2-amino-4-oxo-4,7-dihydro-3h-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)phenyl)acetic acid |
|
107
|
351
|
6p5sA |
Hipk2 kinase domain bound to cx-4945 |
|
80
|
285
|
6pf3A |
Crystal structure of human thymidylate synthase delta (7-29) in complex with dump and 2-(4-((2-amino-4-oxo-4,7-dihydro-3h-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)-4-chlorobenzoic acid |
|
160
|
519
|
6pf7A |
Crystal structure of ts-dhfr from cryptosporidium hominis in complex with nadph, fdump and 2-(4-((2-amino-4-oxo-4,7-dihydro-3h-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)benzoic acid |
|
164
|
519
|
6pfaA |
Crystal structure of ts-dhfr from cryptosporidium hominis in complex with nadph, fdump and 2-((4-((2-amino-4-oxo-4,7-dihydro-3h-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)methyl)benzoic acid. |
|
165
|
519
|
6pfeA |
Crystal structure of ts-dhfr from cryptosporidium hominis in complex with nadph, fdump and 2-(4-((2-amino-4-oxo-4,7-dihydro-3h-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)-4-methoxybenzoic acid. |
|
166
|
519
|
6pf8A |
Crystal structure of ts-dhfr from cryptosporidium hominis in complex with nadph, fdump and 2-(4-((2-amino-4-oxo-4,7-dihydro-3h-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)-4-chlorobenzoic acid |
|
153
|
519
|
6pfiA |
Crystal structure of ts-dhfr from cryptosporidium hominis in complex with nadph, fdump and 3-(4-((2-amino-4-oxo-4,7-dihydro-3h-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)-4-(carboxymethyl)benzoic acid. |
|
135
|
519
|
6pfbA |
Crystal structure of ts-dhfr from cryptosporidium hominis in complex with nadph, fdump and 3-(2-(4-((2-amino-4-oxo-4,7-dihydro-3h-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)phenyl)propanoic acid. |
